Study design. This prospective, randomized, controlled, parallel-group study compared the use of pen devices with conventional vials and syringes for the administration of insulin in hospitalized ...

Dublin, May 20, 2026 (GLOBE NEWSWIRE) -- The "Insulin Delivery Devices Market Size, Share & Trends Analysis Report by Product, End Use, Region, and Growth Forecasts, 2026-2033" report has been added ...

Companion Medical, a stealthy San Diego-based company that received funding last year from Eli Lilly and Company, has received FDA 510(k) clearance for its Bluetooth-connected smart insulin pen and ...

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin pens to $1 per device in low- and middle-income countries (LMICs). Pens are ...

The MarketWatch News Department was not involved in the creation of this content. Insulin Delivery Devices Market: 7.82% CAGR to 2031 Driven by Digital Insulin Pens and Pumps Transforming Diabetes ...

Novo Nordisk, a global healthcare company and leader in diabetes care, today announced a $73 million expansion of its Clayton, NC manufacturing facility to accommodate increased production capacity ...

Embecta Corp (NASDAQ:EMBC), a manufacturer of disposable insulin pen needles and syringes, is considering a potential sale following a significant drop in its share price since being spun off from ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted 501(k) clearance to a smart cap sensor for disposable insulin pens, according to an industry ...

Medtronic Diabetes has been hit with a class action lawsuit. The lawsuit, filed in August 30, 2023 in a California federal court, alleges that Medtronic engaged in “transmission and disclosure” of ...

The US Court of Appeals for the First Circuit last week ruled that Sanofi improperly submitted a patent for its insulin device in the US Food and Drug Administration’s (FDA) Orange Book and could ...